Polysilicone-15 API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Polysilicone-15 is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Polysilicone-15 or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Polysilicone-15 API 207574-74-1?

Description:
Here you will find a list of producers, manufacturers and distributors of Polysilicone-15. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Polysilicone-15 
Synonyms:
Diethylbenzylidene malonate dimethicone , Diethylmalonylbenzylidene oxypropene dimethicone , Dimethicodiethylbenzalmalonate  
Cas Number:
207574-74-1 
DrugBank number:
DB11271 
Unique Ingredient Identifier:
F8DRP5BB29

General Description:

Polysilicone-15, identified by CAS number 207574-74-1, is a notable compound with significant therapeutic applications. Polysilicone-15 is a silicone based UVB absorber . The compound is a colorless to pale yellow viscous liquid which is soluble in organic solvents of medium polarity and insoluble in water . It is the first polymeric UVB filer consisting of chromophores attached to a silicone backbone . When included in various other cosmetic shampoos, conditioners, or hairsprays the compound also functions as an effective photostabilizer of the product .

Indications:

This drug is primarily indicated for: Polysilicone-15 is used as an UV-filter in cosmetic sunscreen products as well as in other cosmetic products (like shampoos, conditioners, hairsprays, etc.) where it can confer photostability to the product(s) . Its use in specific medical scenarios underscores its importance in the therapeutic landscape.

Metabolism:

Polysilicone-15 undergoes metabolic processing primarily in: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. This metabolic pathway ensures efficient processing of the drug, helping to minimize potential toxicity and side effects.

Absorption:

The absorption characteristics of Polysilicone-15 are crucial for its therapeutic efficacy: Polysilicone-15 is reported as having little to no absorption through the skin . At this time, however, studies demonstrate that the components of most commonly used sunscreens are likely absorbed into the skin at least to some extent - although penetration to deeper tissues and the cutaneous circulation remains limited . Despite the extensive use of sunscreen products around the world, there have been few reports of adverse effects related to their use . The drug's ability to rapidly penetrate into cells ensures quick onset of action.

Half-life:

The half-life of Polysilicone-15 is an important consideration for its dosing schedule: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. This determines the duration of action and helps in formulating effective dosing regimens.

Protein Binding:

Polysilicone-15 exhibits a strong affinity for binding with plasma proteins: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. This property plays a key role in the drug's pharmacokinetics and distribution within the body.

Route of Elimination:

The elimination of Polysilicone-15 from the body primarily occurs through: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. Understanding this pathway is essential for assessing potential drug accumulation and toxicity risks.

Volume of Distribution:

Polysilicone-15 is distributed throughout the body with a volume of distribution of: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. This metric indicates how extensively the drug permeates into body tissues.

Clearance:

The clearance rate of Polysilicone-15 is a critical factor in determining its safe and effective dosage: Polysilicone-15 is reported as having little to no absorption through the skin . The systemic presence of the compound is consequently expected to be minimal. It reflects the efficiency with which the drug is removed from the systemic circulation.

Pharmacodynamics:

Polysilicone-15 exerts its therapeutic effects through: As an active ingredient in sunscreen products, polysilicone-15 is applied directly onto human skin where it acts as a chemical sunscreen layer between skin and sunlight that also directly absorbs the UV sunlight radiation . When used in combination with other ingredients in cosmetic shampoos, conditioners, hairsprays, etc. the photostable polysilicone-15 confers photostability onto the entire combined product, protecting it from deterioration in the sunlight by absorbing the UV light radiation . Additionally, there have been studies suggesting polysilicone-15 is also considered to have little to no absorption through the skin , so little systemic exposure and pharmacokinetics are expected and users can freely wash off and re-apply the compound as necessary. The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.

Mechanism of Action:

Polysilicone-15 functions by: Ultraviolet radiation is the invisible energy component to sunlight and consists of three wavelength ranges: (a) UVA is long-range UV radiation between 320-400nm . Although not as energetic as UVB, UVA can penetrate deep into the dermis . UVA can cause immediate tanning, premature skin aging, and can also play a role in the formation of some skin cancers . Approximately 95% of UVA from the sun passes through Earth's ozone layer . (b) UVB is short-wavelength UV radiation between 280-320nm . It is capable of penetrating the outer protective layer of the skin and is responsible for delayed tanning, sunburns, and most skin cancers . A large amount of UVB is absorbed by the ozone layer, however, as only 5% reaches the Earth's surface . (c) UVC is comprised of wavelengths between 100-280nm and is very energetic . It is very dangerous to all forms of life, even when the exposure is short . However, UVC radiation is generally filtered out by the ozone layer and never reaches the Earth . Ultimately, the shorter the wavelength, the more harmful the UV radiation - although shorter wavelength UV radiation is less able to penetrate the skin . Polysilicone-15 is comprised of chromophores that are attached to polysiloxane chains in a controlled manner with optimal micro-distance between chromophores . This arrangement forms a flexible film that disperses the chromophores in a way that effectively falls into and flows about the natural ergonomics of the skin surface - as opposed to how conventional UV filters tend to accumulate in the troughs of the skin . Regardless, polysilicone-15 is specifically a UVB filter and is often combined with other approved UV filters to achieve a wide range of UV protection . Finally, polysilicone-15 is itself photostable, containing specialized chemicals that take excited state energy away from molecules of the compound that have absorbed high-energy UV light particles and return the molecules to the ground state, ready to absorb more UV radiation and having been spared from various photochemical reactions that would have been facilitated by the retention of the high energy UV radiation, had it not been neutralized by the photostabilizer chemicals . When combined with other ingredients in cosmetic shampoo, conditioner, and hairspray products this photostability is conferred upon the entire combination product, allowing the product to remain intact after it has been applied to hair and exposed to sunlight outdoors . This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.

Toxicity:

Categories:

Polysilicone-15 is categorized under the following therapeutic classes: Sunscreen Agents. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Polysilicone-15 is a type of Anticancer drugs


Anticancer drugs belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category designed specifically to combat cancer cells. These powerful medications play a crucial role in cancer treatment and are developed to target and destroy cancerous cells, preventing their growth and spread.

Anticancer drugs are classified based on their mode of action and can include various types such as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormonal therapy drugs. Chemotherapy drugs work by interfering with the cell division process, thereby inhibiting the growth of cancer cells. Targeted therapy drugs, on the other hand, are designed to attack specific molecules or genes involved in cancer growth, minimizing damage to healthy cells. Immunotherapy drugs stimulate the body's immune system to recognize and destroy cancer cells. Hormonal therapy drugs are used in cancers that are hormone-dependent, such as breast or prostate cancer, to block the hormones that fuel cancer cell growth.

These APIs are typically synthesized through complex chemical processes in state-of-the-art manufacturing facilities. Stringent quality control measures ensure the purity, potency, and safety of these drugs. Anticancer APIs undergo rigorous testing and adhere to stringent regulatory guidelines before being approved for clinical use.

Due to their critical role in cancer treatment, anticancer drugs are in high demand worldwide. Researchers and pharmaceutical companies continually strive to develop new and more effective APIs in this category to enhance treatment outcomes and minimize side effects. The ongoing advancements in the field of anticancer drug development offer hope for improved cancer therapies and better patient outcomes.